Hand-foot syndrome associated with liposome-encapsulated doxorubicin therapy

Abstract

Hand-foot syndrome can be debilitating and may be a limiting factor in the prolonged use of DOX-SL for AIDS-related KS for some patients. It is critical for clinicians using this drug to identify this side effect to limit HFS-associated morbidity.